Range Low Price High Price Comment
30 days $0.0470 $0.0600 Thursday, 28th Mar 2024 BLPH stock ended at $0.0568. During the day the stock fluctuated 0% from a day low at $0.0568 to a day high of $0.0568.
90 days $0.0333 $0.0785
52 weeks $0.0290 $12.58

Historical Bellerophon Therapeutics prices

Date Open High Low Close Volume
2024-01-17 $0.0555 $0.0785 $0.0456 $0.0641 52 731
2024-01-16 $0.0650 $0.0650 $0.0494 $0.0573 324 948
2024-01-12 $0.0520 $0.0610 $0.0450 $0.0590 400 226
2024-01-11 $0.0557 $0.0590 $0.0495 $0.0590 79 162
2024-01-10 $0.0440 $0.0597 $0.0430 $0.0590 305 697
2024-01-09 $0.0390 $0.0450 $0.0390 $0.0430 282 986
2024-01-08 $0.0375 $0.0390 $0.0375 $0.0390 85 034
2024-01-05 $0.0385 $0.0400 $0.0385 $0.0385 34 542
2024-01-04 $0.0384 $0.0384 $0.0384 $0.0384 150 014
2024-01-03 $0.0370 $0.0397 $0.0370 $0.0391 34 087
2024-01-02 $0.0370 $0.0410 $0.0370 $0.0370 13 528
2023-12-29 $0.0340 $0.0450 $0.0333 $0.0370 121 736
2023-12-28 $0.0300 $0.0355 $0.0300 $0.0340 351 473
2023-12-27 $0.0300 $0.0333 $0.0300 $0.0310 279 967
2023-12-26 $0.0326 $0.0333 $0.0320 $0.0330 99 471
2023-12-22 $0.0300 $0.0350 $0.0300 $0.0350 57 291
2023-12-21 $0.0321 $0.0353 $0.0320 $0.0320 86 733
2023-12-20 $0.0323 $0.0340 $0.0300 $0.0321 233 786
2023-12-19 $0.0325 $0.0340 $0.0323 $0.0323 128 253
2023-12-18 $0.0335 $0.0340 $0.0325 $0.0325 252 234
2023-12-15 $0.0335 $0.0370 $0.0335 $0.0370 161 932
2023-12-14 $0.0325 $0.0364 $0.0325 $0.0336 12 404
2023-12-13 $0.0368 $0.0368 $0.0336 $0.0336 2 650
2023-12-12 $0.0325 $0.0380 $0.0325 $0.0380 4 505
2023-12-11 $0.0384 $0.0419 $0.0328 $0.0328 38 848
Click to get the best stock tips daily for free!

About Bellerophon Therapeutics

Bellerophon Therapeutics Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT